B. Oehrle

Validated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assay

M. Irmler, J. Beckers, O. Eickelberg, 2015, Scientific Reports.

Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.

T. Luedde, J. Mayerle, D. Teupser, 2022, Future oncology.

Autocrine Sfrp1 inhibits lung fibroblast invasion during transition to injury induced myofibroblasts

C. Samakovlis, H. Schiller, M. Irmler, 2022, bioRxiv.

Editor’s Highlight: Therapeutic Concentrations of Antidepressants Inhibit Pancreatic Beta-Cell Function via Mitochondrial Complex Inhibition

Paul A. Smith, A. Helaly, E. Elmorsy, 2017, Toxicological sciences : an official journal of the Society of Toxicology.

Multiplex Profiling of Cellular Invasion in 3D Cell Culture Models

M. Lindner, O. Eickelberg, G. Burgstaller, 2013, PloS one.

The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease

H. Schiller, O. Eickelberg, E. White, 2017, European Respiratory Journal.

Supplemental : Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

C. Pilarsky, R. Grützmann, J. Weitz, 2016 .

Independent validation and assay standardization of improved metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.

C. Pilarsky, R. Grützmann, J. Weitz, 2022, Gastroenterology.

[Diabetes and pancreatic cancer - state of the art].

J. Mayerle, E. Goni, B. Oehrle, 2020, MMW Fortschritte der Medizin.

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma

C. Pilarsky, R. Grützmann, W. Uhl, 2021, Cells.